203 related articles for article (PubMed ID: 25293429)
1. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.
Arthur C; Tang X; Romero JR; Gossett JG; Harik N; Prodhan P
Pediatr Cardiol; 2015 Mar; 36(3):509-15. PubMed ID: 25293429
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
[TBL] [Abstract][Full Text] [Related]
4. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM
Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
Wang L; Zhou W; Cao Y; Yang C; Liu H; Chen T; Chen L
Medicine (Baltimore); 2020 Feb; 99(8):e19250. PubMed ID: 32080131
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Wang CH; Yu CM; Hsu ST; Wu RX
J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
[TBL] [Abstract][Full Text] [Related]
7. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M
J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia: rare cause of meningitis.
Correia CR; Ferreira ST; Nunes P
Pediatr Int; 2014 Aug; 56(4):e21-2. PubMed ID: 25252064
[TBL] [Abstract][Full Text] [Related]
12. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
Sattler CA; Mason EO; Kaplan SL
Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
[TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G
Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China.
Xun M; Zhang Y; Li BL; Wu M; Zong Y; Yin YM
J Infect Dev Ctries; 2014 Aug; 8(8):1000-5. PubMed ID: 25116665
[TBL] [Abstract][Full Text] [Related]
15. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
16. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
17. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures.
Kwa AL; Low JG; Lim TP; Leow PC; Kurup A; Tam VH
Ann Acad Med Singap; 2008 Oct; 37(10):826-30. PubMed ID: 19037515
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of six-year
Ince N; Yekenkurul D; Danış A; Çalışkan E; Akkaş İ
Afr Health Sci; 2020 Sep; 20(3):1118-1123. PubMed ID: 33402956
[TBL] [Abstract][Full Text] [Related]
19. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study.
Wang CH; Lin JC; Chang FY; Yu CM; Lin WS; Yeh KM
J Microbiol Immunol Infect; 2017 Oct; 50(5):646-652. PubMed ID: 28688829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
